Global Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,800	296 Pages	Data Bridge Market Research	May, 2022	DAABD17330401

Best Price Guarantee
Price	from $4,800
Length	296 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330401

Global Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Global psychedelic drugs market is projected to register a substantial CAGR of 13.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Global Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), Country (North America, Europe, Asia-Pacific, Middle East and Africa and South America) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the global psychedylic drugs market are:
• Growing acceptance of psychedelic drugs for treating depression
• Increasing Prevalence Of Depression And Mental Disorders

Market Players
The key market players for global psychedelic drugs market are listed below:
• Jazz Pharmaceuticals, Inc.
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Hikma Pharmaceuticals PLC
• COMPASS
• Verrian
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Avadel
• Celon Pharma SA.
• Cybin Corp.
• GH Research
• Entheon Biomedical Corp
• PharmaTher Holdings Ltd.
• NRx Pharmaceuticals, Inc.
• usonainstitute.org

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Global Psychedelic Drugs Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pipeline Analysis; 4.2 Pestel Analysis; 4.3 Porter's Five Forces Model
5 Regulatory Framework: Global Psychedelic Drugs Market: 5.1 Regulatory Scenario In The U.S.; 5.2 Regulatory Scenario In The U.K.; 5.3 Regulatory Scenario In India; 5.4 Regulatory Scenario In Uae; 5.5 Regulatory Scenario In Africa; 5.6 Regulatory Scenario In Brazil
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression; 6.1.2 Increasing Prevalence Of Depression And Mental Disorders; 6.1.3 Rising Awareness Toward Mental Health; 6.1.4 Ongoing Clinical Trials; 6.1.5 Rise In Product Approvals; 6.2 Restraints; 6.2.1 Stringent Regulations For Psychedelic Drugs; 6.2.2 High Cost Of Psychedelic Drugs; 6.2.3 Patent Expiry Of Psychedelic Drugs; 6.3 Opportunities; 6.3.1 Increasing R&D Activities In Psychedelic Drugs; 6.3.2 Breakthrough Therapy Designation By Regulatory Authority; 6.3.3 Upcoming Rehabilitation Centers; 6.3.4 Availability Of Certified Healthcare Professionals; 6.4 Challenges; 6.4.1 Side Effects Associated With Psychedelic Drugs; 6.4.2 Rise In Illegal Alternatives; 6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The Global Psychedelic Drugs Market: 7.1 Impact On Price; 7.2 Impact On Demand; 7.3 Impact On Supply Chain; 7.4 Strategic Decisions For Manufacturers; 7.5 Conclusion
8 Global Psychedelic Drugs Market, By Type: 8.1 Overview; 8.2 Empathogens; 8.3 Dissociatives; 8.4 Others
9 Global Psychedelic Drugs Market, By Source: 9.1 Overview; 9.2 Synthetic; 9.3 Natural
10 Global Psychedelic Drugs Market, By Drugs: 10.1 Overview; 10.2 Gamma-hydroxybutyric Acid; 10.3 Ketamine; 10.4 Psilocybin; 10.5 Others
11 Global Psychedelic Drugs Market, By Application: 11.1 Overview; 11.2 Narcolepsy; 11.3 Treatment Resistant Depression; 11.4 Major Depressive Disorder; 11.5 Opiate Addiction; 11.6 Post-traumatic Stress Disorder; 11.7 Others
12 Global Psychedelic Drugs Market, By Route Of Administration: 12.1 Overview; 12.2 Oral; 12.3 Inhalation; 12.4 Injectable
13 Global Psychedelic Drugs Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.3 Specialty Clinics; 13.4 Homecare; 13.5 Others
14 Global Psychedelic Drugs Market, By Distribution Channel: 14.1 Overview; 14.2 Hospitals Pharmacy; 14.3 Retail Pharmacy; 14.4 Online Pharmacy
15 Global Psychedelic Drugs Market, By Region: 15.1 Overview; 15.2 North America; 15.2.1 U.S.; 15.2.2 Canada; 15.2.3 Mexico; 15.3 Europe; 15.3.1 Germany; 15.3.2 U.K.; 15.3.3 France; 15.3.4 Italy; 15.3.5 Spain; 15.3.6 Russia; 15.3.7 Poland; 15.3.8 Switzerland; 15.3.9 Netherlands; 15.3.10 Hungary; 15.3.11 Austria; 15.3.12 Norway; 15.3.13 Ireland; 15.3.14 Belgium; 15.3.15 Lithuania; 15.3.16 Rest Of Europe; 15.4 Asia-pacific; 15.4.1 India; 15.4.2 Australia; 15.4.3 South Korea; 15.4.4 Singapore; 15.4.5 Malaysia; 15.5 Middle East & Africa; 15.5.1 Saudi Arabia; 15.5.2 Israel; 15.5.3 Egypt; 15.5.4 Uae; 15.5.5 South Africa; 15.6 South America; 15.6.1 Brazil; 15.6.2 Argentina; 15.6.3 Rest Of South America
16 Global Psychedelic Drugs Market: Company Landscape: 16.1 Company Share Analysis: Global; 16.2 Company Share Analysis: North America; 16.3 Company Share Analysis: Europe; 16.4 Company Share Analysis: Asia-pacific
17 Swot Analysis
18 Company Profile: 18.1 Jazz Pharmaceuticals, Inc.; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Pfizer Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 F. Hoffmann- La Roche Ltd; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Development; 18.4 Janssen Global Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.); 18.4.1 Company Snapshot; 18.4.2 Company Share Analysis; 18.4.3 Product Portfolio; 18.4.4 Recent Development; 18.5 Avadel; 18.5.1 Company Snapshot; 18.5.2 Product Portfolio; 18.5.3 Recent Development; 18.6 Celon Pharma Sa; 18.6.1 Company Snapshot; 18.6.2 Product Portfolio; 18.6.3 Recent Development; 18.7 Compass; 18.7.1 Company Snapshot; 18.7.2 Product Portfolio; 18.7.3 Recent Developments; 18.8 Cybin Corp.; 18.8.1 Company Snapshot; 18.8.2 Product Portfolio; 18.8.3 Recent Developments; 18.9 Entheon Biomedical Corp; 18.9.1 Company Snapshot; 18.9.2 Product Portfolio; 18.9.3 Recent Development; 18.10 Gh Research; 18.10.1 Company Snapshot; 18.10.2 Product Portfolio; 18.10.3 Recent Development; 18.11 Hikma Pharmaceuticals Plc; 18.11.1 Company Snapshot; 18.11.2 Revenue Analysis; 18.11.3 Product Portfolio; 18.11.4 Recent Developments; 18.12 Nrx Pharmaceuticals, Inc.; 18.12.1 Company Snapshot; 18.12.2 Product Portfolio; 18.12.3 Recent Development; 18.13 Pharmather Holdings Ltd.; 18.13.1 Company Snapshot; 18.13.2 Product Portfolio; 18.13.3 Recent Development; 18.14 Verrian; 18.14.1 Company Snapshot; 18.14.2 Product Portfolio; 18.14.3 Recent Development; 18.15 Usonainstitute.Org; 18.15.1 Company Snapshot; 18.15.2 Product Portfolio; 18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Figures: Figure 1 Global Psychedelic Drugs Market: Segmentation; Figure 2 Global Psychedelic Drugs Market : Data Triangulation; Figure 3 Global Psychedelic Drugs Market: Droc Analysis; Figure 4 Global Psychedelic Drugs Market: Global Vs Regional Market Analysis; Figure 5 Global Psychedelic Drugs Market: Company Research Analysis; Figure 6 Global Psychedelic Drugs Market: Multivariate Modelling; Figure 7 Global Psychedelic Drugs Market: Interview Demographics; Figure 8 Global Psychedelic Drugs Market: Dbmr Market Position Grid; Figure 9 Global Psychedelic Drugs Market: End User Coverage Grid; Figure 10 Global Psychedelic Drugs Market: Vendor Share Analysis; Figure 11 Global Psychedelic Drugs Market: Segmentation; Figure 12 North America Is Expected To Dominate The Global Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 13 Rising Awareness Towards Merantal Health Driving The Global Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029; Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The Global Psychedelic Drugs Market In 2022 & 2029; Figure 15 North America Is The Fastest Growing Market For Psychedelic Drugs Manufacturers In The Forecast Period Of 2022 To 2029; Figure 16 Drivers, Restraints, Opportunities, And Challenges Of The Global Psychedelic Drugs Market; Figure 17 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 19 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender; Figure 20 Global Psychedelic Drugs Market: By Type, 2021; Figure 21 Global Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million); Figure 22 Global Psychedelic Drugs Market: By Type, Cagr (2022-2029); Figure 23 Global Psychedelic Drugs Market: By Type, Lifeline Curve; Figure 24 Global Psychedelic Drugs Market: By Source, 2021; Figure 25 Global Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million); Figure 26 Global Psychedelic Drugs Market: By Source, Cagr (2022-2029); Figure 27 Global Psychedelic Drugs Market: By Source, Lifeline Curve; Figure 28 Global Psychedelic Drugs Market: By Drugs, 2021; Figure 29 Global Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million); Figure 30 Global Psychedelic Drugs Market: By Drugs, Cagr (2022-2029); Figure 31 Global Psychedelic Drugs Market: By Drugs, Lifeline Curve; Figure 32 Global Psychedelic Drugs Market: By Application, 2021; Figure 33 Global Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million); Figure 34 Global Psychedelic Drugs Market: By Application, Cagr (2022-2029); Figure 35 Global Psychedelic Drugs Market: By Application, Lifeline Curve; Figure 36 Global Psychedelic Drugs Market: By Route Of Administration, 2021; Figure 37 Global Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million); Figure 38 Global Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029); Figure 39 Global Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve; Figure 40 Global Psychedelic Drugs Market: By End User, 2021; Figure 41 Global Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million); Figure 42 Global Psychedelic Drugs Market: By End User, Cagr (2022-2029); Figure 43 Global Psychedelic Drugs Market: By End User, Lifeline Curve; Figure 44 Global Psychedelic Drugs Market: By Distribution Channel, 2021; Figure 45 Global Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 46 Global Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029); Figure 47 Global Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve; Figure 48 Global Psychedelic Drugs Market: Snapshot (2021); Figure 49 Global Psychedelic Drugs Market: By Region (2021); Figure 50 Global Psychedelic Drugs Market: By Region (2022 & 2029); Figure 51 Global Psychedelic Drugs Market: By Region (2021 & 2029); Figure 52 Global Psychedelic Drugs Market: By Type (2022-2029); Figure 53 North America Psychedelic Drugs Market: Snapshot (2021); Figure 54 North America Psychedelic Drugs Market: By Country (2021); Figure 55 North America Psychedelic Drugs Market: By Country (2022 & 2029); Figure 56 North America Psychedelic Drugs Market: By Country (2021 & 2029); Figure 57 North America Psychedelic Drugs Market: By Type (2022-2029); Figure 58 Europe Psychedelic Drugs Market: Snapshot (2021); Figure 59 Europe Psychedelic Drugs Market: By Country (2021); Figure 60 Europe Psychedelic Drugs Market: By Country (2022 & 2029); Figure 61 Europe Psychedelic Drugs Market: By Country (2021 & 2029); Figure 62 Europe Psychedelic Drugs Market: By Type (2022-2029); Figure 63 Asia-pacific Psychedelic Drugs Market: Snapshot (2021); Figure 64 Asia-pacific Psychedelic Drugs Market: By Country (2021); Figure 65 Asia-pacific Psychedelic Drugs Market: By Country (2022 & 2029); Figure 66 Asia-pacific Psychedelic Drugs Market: By Country (2021 & 2029); Figure 67 Asia-pacific Psychedelic Drugs Market: By Type (2022-2029); Figure 68 Middle East & Africa Psychedelic Drugs Market: Snapshot (2021); Figure 69 Middle East & Africa Psychedelic Drugs Market: By Country (2021); Figure 70 Middle East & Africa Psychedelic Drugs Market: By Country (2022 & 2029); Figure 71 Middle East & Africa Psychedelic Drugs Market: By Country (2021 & 2029); Figure 72 Middle East & Africa Psychedelic Drugs Market: By Type (2022-2029); Figure 73 South America Psychedelic Drugs Market: Snapshot (2021); Figure 74 South America Psychedelic Drugs Market: By Country (2021); Figure 75 South America Psychedelic Drugs Market: By Country (2022 & 2029); Figure 76 South America Psychedelic Drugs Market: By Country (2021 & 2029); Figure 77 South America Psychedelic Drugs Market: By Type (2022-2029); Figure 78 Global Psychedelic Drugs Market: Company Share 2021 (%); Figure 79 North America Psychedelic Drugs Market: Company Share 2021 (%); Figure 80 Europe Psychedelic Drugs Market: Company Share 2021 (%); Figure 81 Asia-pacific Psychedelic Drugs Market: Company Share 2021 (%)